Swiss authorities target 'live cell' injection clinics

Swiss health regulators announced Thursday they have launched a criminal probe into clinics suspected of giving clients potentially dangerous animal cell injections as part of anti-ageing treatments.

The investigation targets and people who have illegally offered the injections which are particularly popular among wealthy Chinese, Middle Eastern and Russian nationals, said the Federal Office of Public Health (OFSP).

As part of the so-called live cell treatments invented in the 1930s by Swiss doctor Paul Niehans cells extracted from sheep, cow or pig foetuses are injected into patients hoping to roll back the effects of age or searching for renewed vigour.

Authorities say there is no scientific evidence proving the effectiveness of the treatments, which providers also claim can help fight against migraines and chronic conditions like cancer.

Health authorities said they know of at least 35 clinics that offer the treatments yet it appears none of them have the proper permits. The clinics were already warned in 2014 to stop operating without authorisation.

According to Swiss TV the treatments are worth millions of euros per year to the clinics that deliver them.

The head of a travel agency specialising in medical tourism for Chinese people stood up for the cell therapies.

"These treatments work. We have clients who come back every two years," said Swissna agency owner Xu Junhua. "If it didn't work, people wouldn't spend so much money."

The injections, authorities warn, can prompt allergic reactions, abscesses and blood infections. The animal cells can also infect patients with disease-causing pathogens.

© 2015 AFP

Citation: Swiss authorities target 'live cell' injection clinics (2015, March 26) retrieved 14 May 2024 from https://medicalxpress.com/news/2015-03-swiss-authorities-cell-clinics.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Nature reports on unapproved stem-cell therapies in China

10 shares

Feedback to editors